Company / Revenue per Share
KIORA PHARMACEUTICALS INC Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.60
FY2025
5-year range
$0.00 / $0.66
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share returned to growth in FY2025 after 2 years of decline, reaching $0.60.
Based on SEC 10-K filings.
0.60 in FY2025 with a 5-year CAGR of -1.9%.
Improved from $0.00 to $0.60 over the past 4 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -1.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak revenue per share was recorded in FY2020.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.60 | - |
| FY2024 | $0.00 | -100.0% |
| FY2021 | $0.00 | -99.7% |
| FY2020 | $0.66 | +21.1% |
| FY2019 | $0.54 | +2203.0% |
| FY2018 | $0.02 | -64.3% |
| FY2017 | $0.07 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026